For research and educational purposes only. Not medical advice.
S-4 Reference
Educational, not medical advice reference for S-4: SARM, Fat Loss; regulatory status, evidence posture, source review, and schedule notes. Also known as Anda…
Reference summary
Published work is preclinical and small early-phase human exposure. No outcome program for body-composition use exists.
- Categories
- SARM, Fat Loss
- Aliases
- Andarine, GTx-007, Non-steroidal SARM
- Evidence posture
- preclinical — FDA enforcement attention. Sold only as a research chemical, not for human consumption per legal seller terms. WADA-prohibited under category S1.2 at all times. Visual disturbances (yellow / blue tint, dim-light adaptation) are widely reported and have led to discontinuation in human trials. No FDA-approved drug label.
- Regulatory status
- No FDA-approved S-4 drug label. WADA prohibits SARMs under category S1.2 at all times. FDA enforcement against SARMs sellers applies. Community accounts report distinctive yellow / blue visual disturbances at active doses.
- Content review status
- research reference